A French SPAC centered on manufacturing and a biotech are pushing into a new CDMO venture.
PPF Biotech, the biotech division of the PPF group that develops and produces immunotherapies, has agreed to sell SCTbio, a cell therapy CDMO, to the French SPAC eureKING. PPF Biotech and eureKING will enter into a joint initiative to build a new CDMO that’s listed on the Paris-based Euronext stock exchange.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.